The DOI matches its Crossref record; 218 of the 218 references it cites were found in a registry or an index.
Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes
Open accessAbstract
The prevalence of type 2 diabetes continues to increase at an alarming rate around the world, with even more people being affected by prediabetes. Although the pathogenesis and long-term complications of type 2 diabetes are fairly well known, its treatment has remained challenging, with only half of the patients achieving the recommended hemoglobin A1c target. This narrative review explores the pathogenetic rationale for the treatment of type 2 diabetes, with the view of fostering better understanding of the evolving treatment modalities. The diagnostic criteria including the role of hemoglobin A1c in the diagnosis of diabetes are discussed. Due attention is given to the different therapeutic maneuvers and their utility in the management of the diabetic patient. The evidence supporting the role of exercise, medical nutrition therapy, glucose monitoring, and antiobesity measures including pharmacotherapy and bariatric surgery is discussed. The controversial subject of optimum glycemic control in hospitalized and ambulatory patients is discussed in detail. An update of the available pharmacologic options for the management of type 2 diabetes is provided with particular emphasis on newer and emerging modalities. Special attention has been given to the initiation of insulin therapy in patients with type 2 diabetes, with explanation of the pathophysiologic basis for insulin therapy in the ambulatory diabetic patient. A review of the evidence supporting the efficacy of the different preventive measures is also provided.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–218 of 218
The impact of nuts on diabetes and diabetes risk
Lovejoy, J. C. (2005) · Current Diabetes Reports · doi:10.1007/s11892-005-0097-x · Cited by 38
Wertz, D. A., Chang, C., Sarawate, C. A., Willey, V. J., Cziraky, M. J., & Bohn, R. L. (2010) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.109.911461 · Cited by 35
Glass, L. C., Qu, Y., Lenox, S. M., Kim, D. S., Gates, J. R., Brodows, R. G., TRAUTMANN, M. E., & Bergenstal, R. M. (2008) · Current Medical Research and Opinion · doi:10.1185/030079908x260862 · Cited by 31
Prevention of type 2 diabetes: the long and winding road
Misra, A. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61631-7 · Cited by 27
Hemoglobin A1c determination in the A1C-Derived Average Glucose (ADAG) study
Lenters‐Westra, E., & Slingerland, R. J. (2008) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2008.322 · Cited by 26
Tight glucose control and hypoglycemia
Preiser, J.-C., & Brunkhorst, F. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31816a16d0 · Cited by 25
Bariatric Surgery and Diabetes: Who Should Be Offered the Option of Remission?
Purnell, J. Q., & Flum, D. R. (2009) · JAMA · doi:10.1001/jama.2009.541 · Cited by 24 · cited 1×
“However, surgical weight reduction is not without risks [41,42].”
BackgroundApproaches to Treatment of Type 2 Diabetes
Bloomgarden, Z. T. (2008) · Diabetes Care · doi:10.2337/dc08-zb08 · Cited by 23
(2004) · Diabetes Care · doi:10.2337/diacare.27.5.1255 · Cited by 23
Ceriello, A., Lush, C. W., Darsow, T., Piconi, L., Corgnali, M., Nanayakkara, N., Frías, J. P., & Maggs, D. G. (2007) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.765 · Cited by 22
A small-molecule glucokinase activator lowers blood glucose in the sulfonylurea-desensitized rat
Ohyama, S., Takano, H., Iino, T., Nishimura, T., Zhou, Y.-P., Langdon, R. B., Zhang, B. B., & Eiki, J. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.04.054 · Cited by 19
Perioperative management of diabetes
Edelson, G. W., FACHNIE, J. D., & Whitehouse, F. W. (2025) · doi:10.1093/med/9780198831846.003.0016 · Cited by 15
Self-Monitoring of Blood Glucose in Patients With Type 2 Diabetes Who Are Not Using Insulin
Welschen, L. M. C., Bloemendal, E., Nijpels, G., Dekker, J. M., Heine, R. J., Stalman, W. A. B., & Bouter, L. M. (2005) · Diabetes Care · doi:10.2337/diacare.28.10.2597a · Cited by 13
Diabetes risk: antioxidants or lifestyle?
Meydani, M., & Azzi, A. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28177 · Cited by 9
A Mistaken Diagnosis of Type 2 Diabetes Due to Hemoglobin N-Baltimore
Nyenwe, E. A., & Fisher, J. N. (2008) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e318164bcd3 · Cited by 7
Self-citationWebb, I. G., Williams, R., & Marber, M. S. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.11.006 · Cited by 7
Long-term Risk of Cardiovascular Events With Rosiglitazone: A Meta-analysis
Singh, S., Loke, Y. K., & Furberg, C. D. (2007) · JAMA · doi:10.1001/jama.298.10.1189 · Cited by 5
Amylin and Insulin Interact to Reduce Food Intake in Rats
Rushing, P., Lutz, T., Seeley, R., & Woods, S. (2000) · Hormone and Metabolic Research · doi:10.1055/s-2007-978590
Cited by
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetologia · doi:10.1007/s00125-012-2534-0 · Cited by 3,919
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetes Care · doi:10.2337/dc12-0413 · Cited by 3,207
Sun, Y., Shi, H., Yin, S., Ji, C., Zhang, X., Zhang, B., Wu, P., Shi, Y., Mao, F., Yan, Y., et al. (2018) · ACS Nano · doi:10.1021/acsnano.7b07643 · Cited by 460
Introduction to Diabetes Mellitus
Kaul, K., Tarr, J. M., Ahmad, S. I., Kohner, E. M., & Chibber, R. (2013) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4614-5441-0_1 · Cited by 322
Human umbilical cord mesenchymal stem cells derived-exosomes in diseases treatment
Yaghoubi, Y., Movassaghpour, A., Zamani, M., Talebi, M., Mehdizadeh, A., & Yousefi, M. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116733 · Cited by 294
Metadata
- Authors
- Nyenwe, E. A., Jerkins, T. W., Umpierrez, G. E., & Kitabchi, A. E.
- Venue
- Metabolism
- Publisher
- Elsevier BV
- Published
- 2011-01
- Volume
- 60
- Issue
- 1
- Pages
- 1-23
- ISSN
- 0026-0495 (ISSN-L)
- OpenAlex
- W2012312748
- Cited by
- 343
- References
- 218
- FWCI
- 11.01
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.